Distinguished in Hypopituitarism

Dr. Maria Fleseriu

Endocrinology
University Andrology Lab LLC
3303 S Bond Ave, 
Portland, OR 
Offers Telehealth
Distinguished in Hypopituitarism
University Andrology Lab LLC
3303 S Bond Ave, 
Portland, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Maria Fleseriu is an Endocrinologist in Portland, Oregon. Dr. Fleseriu is rated as a Distinguished provider by MediFind in the treatment of Hypopituitarism. Her top areas of expertise are Acromegaly, Cushing's disease, Cushing's syndrome, Acromegaloid Facial Appearance Syndrome, and Hormone Replacement Therapy (HRT).

Her clinical research consists of co-authoring 254 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 11 articles in the study of Hypopituitarism.

Specialties
Endocrinology
Licenses
Internal Medicine in OR
Hospital Affiliations
Ohsu Hospital And Clinics
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AllCare Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser
  • EPO
  • HMO
  • POS
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
OHSU Health
  • MANAGED MEDICAID PLAN
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Samaritan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

University Andrology Lab LLC
3303 S Bond Ave, Portland, OR 97239
Call: 503-494-4314
Other Locations
OHSU Hospital
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Call: 503-494-8311

Additional Areas of Focus

Dr. Fleseriu has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: June 19, 2025
Intervention Type: Drug
Study Drug: Levoketoconazole
Study Phase: Phase 3
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
Enrollment Status: Completed
Publish Date: December 18, 2024
Intervention Type: Drug
Study Drug: Osilodrostat
Study Phase: Phase 2
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: November 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: November 01, 2021
Intervention Type: Drug
Study Phase: Phase 3
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: April 19, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ATR-101 for the Treatment of Cushing's Syndrome
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ATR-101 for the Treatment of Cushing's Syndrome
Enrollment Status: Terminated
Publish Date: March 02, 2021
Intervention Type: Drug
Study Phase: Phase 2
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: January 06, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

254 Total Publications

Hypercoagulability in Cushing's syndrome: past, present, future.
Hypercoagulability in Cushing's syndrome: past, present, future.
Journal: Archives of endocrinology and metabolism
Published: November 28, 2025
View All 254 Publications
Similar Doctors
Advanced in Hypopituitarism
Dr. Katherine Chubinskaya
Endocrinology
Advanced in Hypopituitarism
Dr. Katherine Chubinskaya
Endocrinology

Diabetes Endocrine And Weight Management At PeaceHealth Salmon Creek Clinic

2312 NE 129th St Ste 120, 
Vancouver, WA 
 (15.9 miles away)
360-546-8900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Katherine Chubinskaya is an Endocrinologist in Vancouver, Washington. Dr. Chubinskaya is rated as an Advanced provider by MediFind in the treatment of Hypopituitarism. Her top areas of expertise are Pediatric Growth Hormone Deficiency, Hypogonadotropic Hypogonadism, Kallmann Syndrome, and Hypogonadism.

Advanced in Hypopituitarism
Dr. Chaim Vanek
Endocrinology
Advanced in Hypopituitarism
Dr. Chaim Vanek
Endocrinology

OHSU Cho Beaverton

15700 SW Greystone Ct, 
Beaverton, OR 
 (7.5 miles away)
503-494-3442
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Chaim Vanek is an Endocrinologist in Beaverton, Oregon. Dr. Vanek is rated as a Distinguished provider by MediFind in the treatment of Hypopituitarism. His top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Osteitis Fibrosa, and Parathyroid Hyperplasia.

Advanced in Hypopituitarism
Dr. Troy Dillard
Endocrinology
Advanced in Hypopituitarism
Dr. Troy Dillard
Endocrinology

Legacy Medical Group-Endocrinology At Meridian Park

6475 SW Borland Rd Ste L, 
Tualatin, OR 
 (9.6 miles away)
503-692-2300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Troy Dillard is an Endocrinologist in Tualatin, Oregon. Dr. Dillard is rated as an Advanced provider by MediFind in the treatment of Hypopituitarism. His top areas of expertise are Thyroid Storm, Graves Disease, Hyperthyroidism, and Type 2 Diabetes (T2D).

VIEW MORE HYPOPITUITARISM DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fleseriu's expertise for a condition
ConditionClose
  • Elite
  • Acromegaloid Facial Appearance Syndrome
    Dr. Fleseriu is
    Elite
    . Learn about Acromegaloid Facial Appearance Syndrome.
    See more Acromegaloid Facial Appearance Syndrome experts
  • Acromegaly
    Dr. Fleseriu is
    Elite
    . Learn about Acromegaly.
    See more Acromegaly experts
  • Cushing's disease
    Dr. Fleseriu is
    Elite
    . Learn about Cushing's disease.
    See more Cushing's disease experts
  • Cushing's syndrome
    Dr. Fleseriu is
    Elite
    . Learn about Cushing's syndrome.
    See more Cushing's syndrome experts
  • Hypertrichosis-Acromegaloid Facial Appearance Syndrome
    Dr. Fleseriu is
    Elite
    . Learn about Hypertrichosis-Acromegaloid Facial Appearance Syndrome.
    See more Hypertrichosis-Acromegaloid Facial Appearance Syndrome experts
  • Hypothalamic Tumor
    Dr. Fleseriu is
    Elite
    . Learn about Hypothalamic Tumor.
    See more Hypothalamic Tumor experts
View All 9 Elite Conditions
  • Distinguished
  • Addison's Disease
    Dr. Fleseriu is
    Distinguished
    . Learn about Addison's Disease.
    See more Addison's Disease experts
  • Gigantism
    Dr. Fleseriu is
    Distinguished
    . Learn about Gigantism.
    See more Gigantism experts
  • Growth Hormone Deficiency (GHD)
    Dr. Fleseriu is
    Distinguished
    . Learn about Growth Hormone Deficiency (GHD).
    See more Growth Hormone Deficiency (GHD) experts
  • Hypopituitarism
    Dr. Fleseriu is
    Distinguished
    . Learn about Hypopituitarism.
    See more Hypopituitarism experts
  • Sheehan Syndrome
    Dr. Fleseriu is
    Distinguished
    . Learn about Sheehan Syndrome.
    See more Sheehan Syndrome experts
  • Sotos Syndrome
    Dr. Fleseriu is
    Distinguished
    . Learn about Sotos Syndrome.
    See more Sotos Syndrome experts
  • Advanced
  • Cushing's syndrome due to Adrenal Tumor
    Dr. Fleseriu is
    Advanced
    . Learn about Cushing's syndrome due to Adrenal Tumor.
    See more Cushing's syndrome due to Adrenal Tumor experts
  • Exogenous Cushing's syndrome
    Dr. Fleseriu is
    Advanced
    . Learn about Exogenous Cushing's syndrome.
    See more Exogenous Cushing's syndrome experts
  • Hormone Replacement Therapy (HRT)
    Dr. Fleseriu is
    Advanced
    . Learn about Hormone Replacement Therapy (HRT).
    See more Hormone Replacement Therapy (HRT) experts
  • Hypogonadism
    Dr. Fleseriu is
    Advanced
    . Learn about Hypogonadism.
    See more Hypogonadism experts
  • Hypogonadotropic Hypogonadism
    Dr. Fleseriu is
    Advanced
    . Learn about Hypogonadotropic Hypogonadism.
    See more Hypogonadotropic Hypogonadism experts
  • Isolated Hypogonadotropic Hypogonadism
    Dr. Fleseriu is
    Advanced
    . Learn about Isolated Hypogonadotropic Hypogonadism.
    See more Isolated Hypogonadotropic Hypogonadism experts
View All 8 Advanced Conditions
  • Experienced
  • Adrenal Cancer
    Dr. Fleseriu is
    Experienced
    . Learn about Adrenal Cancer.
    See more Adrenal Cancer experts
  • Adrenal Gland Adenoma
    Dr. Fleseriu is
    Experienced
    . Learn about Adrenal Gland Adenoma.
    See more Adrenal Gland Adenoma experts
  • Deafness Hypogonadism Syndrome
    Dr. Fleseriu is
    Experienced
    . Learn about Deafness Hypogonadism Syndrome.
    See more Deafness Hypogonadism Syndrome experts
  • Ectopic Cushing's syndrome
    Dr. Fleseriu is
    Experienced
    . Learn about Ectopic Cushing's syndrome.
    See more Ectopic Cushing's syndrome experts
  • Empty Sella Syndrome
    Dr. Fleseriu is
    Experienced
    . Learn about Empty Sella Syndrome.
    See more Empty Sella Syndrome experts
  • Fractured Spine
    Dr. Fleseriu is
    Experienced
    . Learn about Fractured Spine.
    See more Fractured Spine experts
View All 22 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.